Institute of Biomedicine of Seville (IBiS), Virgen del Rocío University Hospital (HUVR)/Consejo Superior de Investigaciones Científicas (CSIC)/University of Seville, Seville, Spain.
Universitat Rovira i Virgili, Instituto de Investigación Sanitaria Pere Virgili (IISPV), Hospital Universitari de Tarragona Joan XXIII, Tarragona, Spain.
Front Immunol. 2020 Nov 6;11:581307. doi: 10.3389/fimmu.2020.581307. eCollection 2020.
We have previously observed increased levels of inflammatory biomarkers and Th17 as well as Treg cells, but not other T-cell specific alterations, preceding immunodiscordance of successfully-treated HIV-infected subjects. Our hypothesis is that this could be related with potential alterations in myeloid-derived suppressor cells (MDSCs) and/or monocyte subsets.
We determined the frequencies of MDSCs and monocyte subsets and the expression of several functional markers (CCR2, 7-integrin, IDO, PDL1, CD11b) in HIV-infected subjects before treatment. We additionally analyzed follow-up samples after 24 months of suppressive cART in a subgroup of subjects. Bivariate regressions were performed, and correlations with soluble proinflammatory and bacterial translocation biomarkers, as well as with Th17/Treg ratio and anti-CMV titers were explored.
Increased frequencies of MDSCs, but normal distribution of monocyte subsets, preceded immunodiscordance. The expression of several functional markers, such as CCR2, CD16, CD11b and PDL1, on MDSCs and monocyte subsets was altered in this scenario. MDSC and monocyte-related functional markers were associated with soluble biomarkers and T-cell parameters. Several of these cellular alterations were not restored after 24 months of suppressive cART.
An early immunosuppressive environment, characterized by the expansion of MDSCs and Tregs, precedes immunodiscordance and is related with a highly inflammatory status.
我们之前观察到,在成功治疗的 HIV 感染者中,炎症生物标志物和 Th17 以及 Treg 细胞水平升高,但其他 T 细胞特异性改变不明显。我们的假设是,这可能与髓源性抑制细胞(MDSCs)和/或单核细胞亚群的潜在改变有关。
我们在治疗前确定了 HIV 感染者 MDSCs 和单核细胞亚群的频率以及几种功能标志物(CCR2、7-整合素、IDO、PDL1、CD11b)的表达。在一组受试者中,我们还分析了抑制性 cART 治疗 24 个月后的随访样本。进行了双变量回归分析,并探讨了与可溶性促炎和细菌易位生物标志物以及 Th17/Treg 比值和抗 CMV 滴度的相关性。
MDSCs 频率增加,但单核细胞亚群分布正常,先于免疫失调。MDSCs 和单核细胞亚群的几种功能标志物(如 CCR2、CD16、CD11b 和 PDL1)的表达在此情况下发生改变。MDSC 和单核细胞相关的功能标志物与可溶性生物标志物和 T 细胞参数相关。在抑制性 cART 治疗 24 个月后,这些细胞改变中的一些并未恢复。
一种早期的免疫抑制环境,其特征是 MDSCs 和 Tregs 的扩增,先于免疫失调,并与高度炎症状态有关。